Skip to main content
Journal cover image

Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full?

Publication ,  Journal Article
Piccini, JP; Arps, K
Published in: JACC Heart Fail
May 2022

Duke Scholars

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

May 2022

Volume

10

Issue

5

Start / End Page

347 / 349

Location

United States

Related Subject Headings

  • Valsartan
  • Stroke Volume
  • Humans
  • Heart Failure
  • Biphenyl Compounds
  • Aminobutyrates
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Piccini, J. P., & Arps, K. (2022). Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full? JACC Heart Fail, 10(5), 347–349. https://doi.org/10.1016/j.jchf.2022.02.010
Piccini, Jonathan P., and Kelly Arps. “Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full?JACC Heart Fail 10, no. 5 (May 2022): 347–49. https://doi.org/10.1016/j.jchf.2022.02.010.
Piccini JP, Arps K. Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full? JACC Heart Fail. 2022 May;10(5):347–9.
Piccini, Jonathan P., and Kelly Arps. “Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full?JACC Heart Fail, vol. 10, no. 5, May 2022, pp. 347–49. Pubmed, doi:10.1016/j.jchf.2022.02.010.
Piccini JP, Arps K. Sacubitril/Valsartan Therapy for AF and HFpEF: Is the Glass Half Empty or Half Full? JACC Heart Fail. 2022 May;10(5):347–349.
Journal cover image

Published In

JACC Heart Fail

DOI

EISSN

2213-1787

Publication Date

May 2022

Volume

10

Issue

5

Start / End Page

347 / 349

Location

United States

Related Subject Headings

  • Valsartan
  • Stroke Volume
  • Humans
  • Heart Failure
  • Biphenyl Compounds
  • Aminobutyrates
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology